Okyo Pharma Limited (OKYO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2015 | 03-2014 | 03-2013 | 03-2012 | 03-2011 | |
| Operating Expenses | 1,948 | 4,774 | 4,734 | 5,415 | 1,703 |
| Operating Income | -1,948 | -4,774 | -4,734 | -5,415 | -1,703 |
| Interest Expense | N/A | 4 | N/A | N/A | N/A |
| Other Income | -6,307 | -9,148 | 79 | -285 | 87 |
| Pre-tax Income | -8,255 | -13,927 | -4,656 | -5,700 | -1,617 |
| Net Income Continuous | -8,255 | -13,927 | -4,656 | -5,700 | -1,617 |
| Minority Interests | 0 | N/A | 2 | 895 | N/A |
| Net Income | $-8,255 | $-13,927 | $-4,654 | $-4,805 | $-1,617 |
| EPS Basic Total Ops | -0.01 | -0.02 | 0.00 | -0.03 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | -0.02 | 0.00 | -0.03 | 0.00 |
| EPS Diluted Total Ops | -0.01 | -0.02 | 0.00 | -0.03 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | -0.02 | 0.00 | -0.03 | 0.00 |
| EBITDA(a) | $-1,948 | $-13,819 | $-4,710 | $-5,395 | $-1,703 |